Literature DB >> 20832746

Cancer metabolism: is glutamine sweeter than glucose?

Weiqin Lu1, Helene Pelicano, Peng Huang.   

Abstract

Entities:  

Year:  2010        PMID： 20832746      PMCID： PMC2952340          DOI： 10.1016/j.ccr.2010.08.017

Source DB:  PubMed          Journal:  Cancer Cell        ISSN： 1535-6108            Impact factor:   31.743


× No keyword cloud information.
  10 in total

1.  Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species.

Authors:  Sawako Suzuki; Tomoaki Tanaka; Masha V Poyurovsky; Hidekazu Nagano; Takafumi Mayama; Shuichi Ohkubo; Maria Lokshin; Hiroyuki Hosokawa; Toshinori Nakayama; Yutaka Suzuki; Sumio Sugano; Eiichi Sato; Toshitaka Nagao; Koutaro Yokote; Ichiro Tatsuno; Carol Prives
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-29       Impact factor: 11.205

Review 2.  Glycolysis inhibition for anticancer treatment.

Authors:  H Pelicano; D S Martin; R-H Xu; P Huang
Journal:  Oncogene       Date:  2006-08-07       Impact factor: 9.867

Review 3.  Glucose metabolism and cancer.

Authors:  Reuben J Shaw
Journal:  Curr Opin Cell Biol       Date:  2006-10-12       Impact factor: 8.382

4.  Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells.

Authors:  L J Reitzer; B M Wice; D Kennell
Journal:  J Biol Chem       Date:  1979-04-25       Impact factor: 5.157

5.  Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function.

Authors:  Wenwei Hu; Cen Zhang; Rui Wu; Yvonne Sun; Arnold Levine; Zhaohui Feng
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-08       Impact factor: 11.205

6.  Targeting mitochondrial glutaminase activity inhibits oncogenic transformation.

Authors:  Jian-Bin Wang; Jon W Erickson; Reina Fuji; Sekar Ramachandran; Ping Gao; Ramani Dinavahi; Kristin F Wilson; Andre L B Ambrosio; Sandra M G Dias; Chi V Dang; Richard A Cerione
Journal:  Cancer Cell       Date:  2010-09-14       Impact factor: 31.743

7.  c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism.

Authors:  Ping Gao; Irina Tchernyshyov; Tsung-Cheng Chang; Yun-Sil Lee; Kayoko Kita; Takafumi Ochi; Karen I Zeller; Angelo M De Marzo; Jennifer E Van Eyk; Joshua T Mendell; Chi V Dang
Journal:  Nature       Date:  2009-02-15       Impact factor: 49.962

8.  Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis.

Authors:  Ralph J DeBerardinis; Anthony Mancuso; Evgueni Daikhin; Ilana Nissim; Marc Yudkoff; Suzanne Wehrli; Craig B Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-21       Impact factor: 11.205

Review 9.  Is Akt the "Warburg kinase"?-Akt-energy metabolism interactions and oncogenesis.

Authors:  R Brooks Robey; Nissim Hay
Journal:  Semin Cancer Biol       Date:  2008-12-14       Impact factor: 15.707

Review 10.  The interplay between MYC and HIF in cancer.

Authors:  Chi V Dang; Jung-whan Kim; Ping Gao; Jason Yustein
Journal:  Nat Rev Cancer       Date:  2008-01       Impact factor: 60.716
  10 in total
  61 in total

Review 1.  Alterations of metabolic genes and metabolites in cancer.

Authors:  Eric K Oermann; Jing Wu; Kun-Liang Guan; Yue Xiong
Journal:  Semin Cell Dev Biol       Date:  2012-01-28       Impact factor: 7.727

2.  Inhibition of neuronal cell mitochondrial complex I with rotenone increases lipid β-oxidation, supporting acetyl-coenzyme A levels.

Authors:  Andrew J Worth; Sankha S Basu; Nathaniel W Snyder; Clementina Mesaros; Ian A Blair
Journal:  J Biol Chem       Date:  2014-08-12       Impact factor: 5.157

3.  Vaccinia virus requires glutamine but not glucose for efficient replication.

Authors:  Krystal A Fontaine; Roman Camarda; Michael Lagunoff
Journal:  J Virol       Date:  2014-02-05       Impact factor: 5.103

4.  Arginine deprivation and autophagic cell death in cancer.

Authors:  Peter Wojciech Szlosarek
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-16       Impact factor: 11.205

Review 5.  Brain Tumor-Related Epilepsy: a Current Review of the Etiologic Basis and Diagnostic and Treatment Approaches.

Authors:  Jeffrey M Politsky
Journal:  Curr Neurol Neurosci Rep       Date:  2017-09       Impact factor: 5.081

6.  Glutaminase GLS1 Inhibitors as Potential Cancer Treatment.

Authors:  Ahmed F Abdel-Magid
Journal:  ACS Med Chem Lett       Date:  2016-02-01       Impact factor: 4.345

7.  Grainyhead-like 2 Reverses the Metabolic Changes Induced by the Oncogenic Epithelial-Mesenchymal Transition: Effects on Anoikis.

Authors:  Joshua C Farris; Phillip M Pifer; Liang Zheng; Eyal Gottlieb; James Denvir; Steven M Frisch
Journal:  Mol Cancer Res       Date:  2016-04-15       Impact factor: 5.852

8.  Human Intestinal Enteroids as a Model System of Shigella Pathogenesis.

Authors:  Benjamin J Koestler; Cara M Ward; C R Fisher; Anubama Rajan; Anthony W Maresso; Shelley M Payne
Journal:  Infect Immun       Date:  2019-03-25       Impact factor: 3.441

9.  Bromodomain Inhibitors Correct Bioenergetic Deficiency Caused by Mitochondrial Disease Complex I Mutations.

Authors:  Joeva J Barrow; Eduardo Balsa; Francisco Verdeguer; Clint D J Tavares; Meghan S Soustek; Louis R Hollingsworth; Mark Jedrychowski; Rutger Vogel; Joao A Paulo; Jan Smeitink; Steve P Gygi; John Doench; David E Root; Pere Puigserver
Journal:  Mol Cell       Date:  2016-09-22       Impact factor: 17.970

Review 10.  Glutaminolysis as a target for cancer therapy.

Authors:  L Jin; G N Alesi; S Kang
Journal:  Oncogene       Date:  2015-11-23       Impact factor: 9.867
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.